TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

D. E. Shaw & Co., Inc.'s Holding History (CIK: 0001009207)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 38,285,000 Value ($000) $54,577 Avg Close — Range —
Q3 2025
Shares 43,285,000 Value ($000) $48,860 Avg Close — Range —
Q2 2025
Shares 45,689,000 Value ($000) $43,702 Avg Close — Range —
Q1 2025
Shares 41,689,000 Value ($000) $41,602 Avg Close — Range —
Q4 2024
Shares 41,689,000 Value ($000) $39,578 Avg Close — Range —
Q3 2024
Shares 41,689,000 Value ($000) $36,082 Avg Close — Range —
Q2 2024
Shares 41,689,000 Value ($000) $26,743 Avg Close — Range —
Q1 2024
Shares 40,689,000 Value ($000) $25,905 Avg Close — Range —
Q4 2023
Shares 40,689,000 Value ($000) $26,638 Avg Close — Range —
Q3 2023
Shares 40,689,000 Value ($000) $26,279 Avg Close — Range —
Q2 2023
Shares 40,689,000 Value ($000) $33,016 Avg Close — Range —
Q1 2023
Shares 38,189,000 Value ($000) $37,524 Avg Close — Range —
Q4 2022
Shares 38,189,000 Value ($000) $34,756 Avg Close — Range —
Q3 2022
Shares 29,000,000 Value ($000) $29,571 Avg Close — Range —
Q2 2022
Shares 29,000,000 Value ($000) $29,118 Avg Close — Range —
Q1 2022
Shares 28,000,000 Value ($000) $29,869 Avg Close — Range —